Herbal-To-Rx Switch? Zyflamend To Undergo Study For Cancer Prevention
This article was originally published in The Tan Sheet
Executive Summary
Columbia University is initiating a clinical trial to evaluate whether the herbal supplement Zyflamend inhibits the onset of prostate cancer in certain patients